SCHEMBL2270514

SCHEMBL2270514

COC(OC)C1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.38
EPHX1 P07099 1/20 0.32
CA12 O43570 2/20 0.30
CA1 P00915 2/20 0.30
CA2 P00918 2/20 0.30
MMP2 P08253 2/20 0.30
CA9 Q16790 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11844930 0.97 SHBG (0.42) SHBGEPHX1CA12CA1CA2
SCHEMBL15233756 0.97 SHBG (0.42) SHBGEPHX1CA12CA1CA2
SCHEMBL3698331 0.97 SHBG (0.42) SHBGEPHX1CA12CA1CA2
SCHEMBL15233755 0.94
SCHEMBL8734417 0.87
SCHEMBL4068617 0.86 SHBG (0.39) SHBGEPHX1CA12CA1CA2
SCHEMBL18914139 0.84 SHBG (0.32) SHBG
SCHEMBL12065455 0.80 SHBG (0.34) SHBGEPHX1
SCHEMBL8620129 0.79 SHBG (0.42) SHBGEPHX1CA12CA1CA2
SCHEMBL20251096 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114539448-B Catalyst for olefin polymerization and preparation method and application thereof 北京吉海川科技发展有限公司 2024-02-27 CN disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 US disclosed
CN-114539448-A Catalyst for olefin polymerization and preparation method and application thereof 北京吉海川科技发展有限公司 2022-05-27 CN disclosed
EP-1875961-B1 CAPSULAR FINE PARTICLE COMPRISING OLEFINIC POLYMER MITSUI CHEMICALS INC (JP) 2018-08-29 EP disclosed
US-9975831-B2 Method for producing ether compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2018-05-22 US disclosed
WO-2017088738-A1 MODIFIED COMPOUND OF ANDROGRAPHOLIDE 南京明德新药研发股份有限公司 2017-06-01 WO disclosed
US-20150011799-A1 METHOD FOR PRODUCING ETHER COMPOUND TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-01-08 US disclosed
EP-2813482-A1 METHOD FOR PRODUCING ETHER COMPOUND Takasago International Corporation (JP) 2014-12-17 EP disclosed
US-8524697-B2 C20-C21 substituted glucocorticoid receptor agonists MERCK SHARP & DOHME CORP. (US) 2013-09-03 US disclosed
US-8349451-B2 Capsular fine particle comprising olefinic polymer MITSUI CHEMICALS, INC. (JP) 2013-01-08 US disclosed
US-5122492-A Magnesium dihalide, titanium halide or halogen alcoholate on porous metal oxide HIMONT INCORPORATED (US) 1992-06-16 US disclosed
EP-0452156-A2 Solid titanium catalyst component for olefin polymerization, olefin polymerization catalyst, prepolymerized polyolefin-containing catalyst and method of olefin polymerization MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-10-16 EP disclosed
EP-0434082-A2 Components and catalysts for the polymerization of olefins MONTELL NORTH AMERICA INC. (US) 1991-06-26 EP disclosed
US-4978648-A Alkyl-aluminum, diether, magnesium dichloride, titanium halide components; propylene polymerization HIMONT INCORPORATED (US) 1990-12-18 US disclosed
US-4971937-A COORDINATION CATALYSTS OF TITANIUM HALIDES, MAGNESIUM HALIDES AND DI OR POLYETHER COMPOUNDS HIMONT INCORPORATED (US) 1990-11-20 US disclosed
EP-0362705-A2 Catalysts for the polymerization of olefins MONTELL NORTH AMERICA INC. (US) 1990-04-11 EP disclosed
EP-0361494-A2 Components and catalysts for the polymerization of olefins MONTELL NORTH AMERICA INC. (US) 1990-04-04 EP disclosed
US-4237306-A ELECTROPHILIC REACTIONS WITH ALKYL ARYL KETONES TO PRODUCE METHYL ARYL ALKANOATES EMERY INDUSTRIES, INC. (US) 1980-12-02 US disclosed
US-4172955-A REARRANGMENT OF A CINNAMALDEHYDE TO A PHENYLMALONDIALDEHYDE TETRAMETHYL DISACETAL EMERY INDUSTRIES, INC. (US) 1979-10-30 US disclosed
US-4067823-A Thallium(III) reagents supported on montmorillonite clay minerals and oxythallation processes for utilizing same EMERY INDUSTRIES, INC. (US) 1978-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 SHBG 4615/4885EPHX1 4265/4885CA12 1203/4885
US-20150011799-A1 METHOD FOR PRODUCING ETHER COMPOUND CBR3, CYP2E1, HPD SHBG 1516/4885EPHX1 47/4885CA12 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.